Report Detail

Other Global Autologous Cell Therapy Market Growth (Status and Outlook) 2019-2024

  • RnM3561829
  • |
  • 27 June, 2019
  • |
  • Global
  • |
  • 116 Pages
  • |
  • LPI(LP Information)
  • |
  • Other

Autologous cell therapy refers to the injection or delivery of human tissue or cells to the same person to treat pathological conditions. For the same purpose, the stem cells are taken out of the patient, harvested, cultured, and transplanted again to the same person. The purpose of this method is to reduce the chance of rejecting treatment in the body. In addition, autologous cell therapy does not require immunosuppression.

According to this study, over the next five years the Autologous Cell Therapy market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Autologous Cell Therapy business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Autologous Cell Therapy market by product type, application, key companies and key regions.

This study considers the Autologous Cell Therapy value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Bone Marrow
Epidermis
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Neurology
Orthopedics
Cancer
Wound Healing
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
BioTime
Pharmicell
BrainStorm Cell Therapeutics
Opexa Therapeutics
Vericel Corporation
Regeneus
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Autologous Cell Therapy market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Autologous Cell Therapy market by identifying its various subsegments.
Focuses on the key global Autologous Cell Therapy players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Autologous Cell Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Autologous Cell Therapy submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.


Table of Contents

    2019-2024 Global Autologous Cell Therapy Market Report (Status and Outlook)

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Autologous Cell Therapy Market Size 2014-2024
        • 2.1.2 Autologous Cell Therapy Market Size CAGR by Region
      • 2.2 Autologous Cell Therapy Segment by Type
        • 2.2.1 Bone Marrow
        • 2.2.2 Bone Marrow
      • 2.3 Autologous Cell Therapy Market Size by Type
        • 2.3.1 Global Autologous Cell Therapy Market Size Market Share by Type (2014-2019)
        • 2.3.2 Global Autologous Cell Therapy Market Size Growth Rate by Type (2014-2019)
      • 2.4 Autologous Cell Therapy Segment by Application
        • 2.4.1 Neurology
        • 2.4.2 Orthopedics
        • 2.4.3 Cancer
        • 2.4.4 Wound Healing
        • 2.4.5 Other
      • 2.5 Autologous Cell Therapy Market Size by Application
        • 2.5.1 Global Autologous Cell Therapy Market Size Market Share by Application (2014-2019)
        • 2.5.2 Global Autologous Cell Therapy Market Size Growth Rate by Application (2014-2019)

      3 Global Autologous Cell Therapy by Players

      • 3.1 Global Autologous Cell Therapy Market Size Market Share by Players
        • 3.1.1 Global Autologous Cell Therapy Market Size by Players (2017-2019)
        • 3.1.2 Global Autologous Cell Therapy Market Size Market Share by Players (2017-2019)
      • 3.2 Global Autologous Cell Therapy Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 Autologous Cell Therapy by Regions

      • 4.1 Autologous Cell Therapy Market Size by Regions
      • 4.2 Americas Autologous Cell Therapy Market Size Growth
      • 4.3 APAC Autologous Cell Therapy Market Size Growth
      • 4.4 Europe Autologous Cell Therapy Market Size Growth
      • 4.5 Middle East & Africa Autologous Cell Therapy Market Size Growth

      5 Americas

      • 5.1 Americas Autologous Cell Therapy Market Size by Countries
      • 5.2 Americas Autologous Cell Therapy Market Size by Type
      • 5.3 Americas Autologous Cell Therapy Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Autologous Cell Therapy Market Size by Countries
      • 6.2 APAC Autologous Cell Therapy Market Size by Type
      • 6.3 APAC Autologous Cell Therapy Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Autologous Cell Therapy by Countries
      • 7.2 Europe Autologous Cell Therapy Market Size by Type
      • 7.3 Europe Autologous Cell Therapy Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Autologous Cell Therapy by Countries
      • 8.2 Middle East & Africa Autologous Cell Therapy Market Size by Type
      • 8.3 Middle East & Africa Autologous Cell Therapy Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global Autologous Cell Therapy Market Forecast

      • 10.1 Global Autologous Cell Therapy Market Size Forecast (2019-2024)
      • 10.2 Global Autologous Cell Therapy Forecast by Regions
        • 10.2.1 Global Autologous Cell Therapy Forecast by Regions (2019-2024)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global Autologous Cell Therapy Forecast by Type
      • 10.8 Global Autologous Cell Therapy Forecast by Application

      11 Key Players Analysis

      • 11.1 BioTime
        • 11.1.1 Company Details
        • 11.1.2 Autologous Cell Therapy Product Offered
        • 11.1.3 BioTime Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
        • 11.1.4 Main Business Overview
        • 11.1.5 BioTime News
      • 11.2 Pharmicell
        • 11.2.1 Company Details
        • 11.2.2 Autologous Cell Therapy Product Offered
        • 11.2.3 Pharmicell Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
        • 11.2.4 Main Business Overview
        • 11.2.5 Pharmicell News
      • 11.3 BrainStorm Cell Therapeutics
        • 11.3.1 Company Details
        • 11.3.2 Autologous Cell Therapy Product Offered
        • 11.3.3 BrainStorm Cell Therapeutics Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
        • 11.3.4 Main Business Overview
        • 11.3.5 BrainStorm Cell Therapeutics News
      • 11.4 Opexa Therapeutics
        • 11.4.1 Company Details
        • 11.4.2 Autologous Cell Therapy Product Offered
        • 11.4.3 Opexa Therapeutics Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
        • 11.4.4 Main Business Overview
        • 11.4.5 Opexa Therapeutics News
      • 11.5 Vericel Corporation
        • 11.5.1 Company Details
        • 11.5.2 Autologous Cell Therapy Product Offered
        • 11.5.3 Vericel Corporation Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
        • 11.5.4 Main Business Overview
        • 11.5.5 Vericel Corporation News
      • 11.6 Regeneus
        • 11.6.1 Company Details
        • 11.6.2 Autologous Cell Therapy Product Offered
        • 11.6.3 Regeneus Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
        • 11.6.4 Main Business Overview
        • 11.6.5 Regeneus News

      ...

        12 Research Findings and Conclusion

        Summary:
        Get latest Market Research Reports on Autologous Cell Therapy . Industry analysis & Market Report on Autologous Cell Therapy is a syndicated market report, published as Global Autologous Cell Therapy Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Autologous Cell Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,660.00
        $5,490.00
        $7,320.00
        2,938.98
        4,408.47
        5,877.96
        3,436.74
        5,155.11
        6,873.48
        565,616.40
        848,424.60
        1,131,232.80
        305,902.80
        458,854.20
        611,805.60
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report